Global and China Bicalutamide Market Insights, Forecast to 2027

Global and China Bicalutamide Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Bicalutamide Product Introduction
1.2 Market by Type
1.2.1 Global Bicalutamide Market Size Growth Rate by Type
1.2.2 Tablets
1.2.3 Capsule
1.3 Market by Application
1.3.1 Global Bicalutamide Market Size Growth Rate by Application
1.3.2 Single Drug For Prostate Cancer
1.3.3 Combined Chemotherapy For Prostate Cancer
1.3.4 Combined Radiation Therapy Or Castration For Prostate Cancer
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Bicalutamide Market Size, Estimates and Forecasts
2.1.1 Global Bicalutamide Revenue 2016-2027
2.1.2 Global Bicalutamide Sales 2016-2027
2.2 Global Bicalutamide, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Bicalutamide Historical Market Size by Region (2016-2021)
2.3.1 Global Bicalutamide Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Bicalutamide Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Bicalutamide Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Bicalutamide Sales Forecast by Region (2022-2027)
2.4.2 Global Bicalutamide Revenue Forecast by Region (2022-2027)
3 Global Bicalutamide Competitor Landscape by Players
3.1 Global Top Bicalutamide Manufacturers by Sales
3.1.1 Global Bicalutamide Sales by Manufacturer (2016-2021)
3.1.2 Global Bicalutamide Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Bicalutamide Manufacturers by Revenue
3.2.1 Key Bicalutamide Manufacturers Covered: Ranking by Revenue
3.2.2 Global Bicalutamide Revenue by Manufacturers (2016-2021)
3.2.3 Global Bicalutamide Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Bicalutamide Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Bicalutamide Revenue in 2020
3.2.6 Global Bicalutamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Bicalutamide Price by Manufacturers
3.4 Global Bicalutamide Manufacturing Base Distribution, Product Types
3.4.1 Bicalutamide Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bicalutamide Product Type
3.4.3 Date of International Manufacturers Enter into Bicalutamide Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Bicalutamide Market Size by Type (2016-2021)
4.1.1 Global Bicalutamide Sales by Type (2016-2021)
4.1.2 Global Bicalutamide Revenue by Type (2016-2021)
4.1.3 Bicalutamide Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Bicalutamide Market Size Forecast by Type (2022-2027)
4.2.1 Global Bicalutamide Sales Forecast by Type (2022-2027)
4.2.2 Global Bicalutamide Revenue Forecast by Type (2022-2027)
4.2.3 Bicalutamide Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Bicalutamide Market Size by Application (2016-2021)
5.1.1 Global Bicalutamide Sales by Application (2016-2021)
5.1.2 Global Bicalutamide Revenue by Application (2016-2021)
5.1.3 Bicalutamide Price by Application (2016-2021)
5.2 Bicalutamide Market Size Forecast by Application (2022-2027)
5.2.1 Global Bicalutamide Sales Forecast by Application (2022-2027)
5.2.2 Global Bicalutamide Revenue Forecast by Application (2022-2027)
5.2.3 Global Bicalutamide Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Bicalutamide Market Size YoY Growth 2016-2027
6.1.1 China Bicalutamide Sales YoY Growth 2016-2027
6.1.2 China Bicalutamide Revenue YoY Growth 2016-2027
6.1.3 China Bicalutamide Market Share in Global Market 2016-2027
6.2 China Bicalutamide Market Size by Players (International and Local Players)
6.2.1 China Top Bicalutamide Players by Sales (2016-2021)
6.2.2 China Top Bicalutamide Players by Revenue (2016-2021)
6.3 China Bicalutamide Historic Market Review by Type (2016-2021)
6.3.1 China Bicalutamide Sales Market Share by Type (2016-2021)
6.3.2 China Bicalutamide Revenue Market Share by Type (2016-2021)
6.3.3 China Bicalutamide Price by Type (2016-2021)
6.4 China Bicalutamide Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Bicalutamide Sales Forecast by Type (2022-2027)
6.4.2 China Bicalutamide Revenue Forecast by Type (2022-2027)
6.4.3 China Bicalutamide Price Forecast by Type (2022-2027)
6.5 China Bicalutamide Historic Market Review by Application (2016-2021)
6.5.1 China Bicalutamide Sales Market Share by Application (2016-2021)
6.5.2 China Bicalutamide Revenue Market Share by Application (2016-2021)
6.5.3 China Bicalutamide Price by Application (2016-2021)
6.6 China Bicalutamide Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Bicalutamide Sales Forecast by Application (2022-2027)
6.6.2 China Bicalutamide Revenue Forecast by Application (2022-2027)
6.6.3 China Bicalutamide Price Forecast by Application (2022-2027)
7 North America
7.1 North America Bicalutamide Market Size YoY Growth 2016-2027
7.2 North America Bicalutamide Market Facts & Figures by Country
7.2.1 North America Bicalutamide Sales by Country (2016-2021)
7.2.2 North America Bicalutamide Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Bicalutamide Market Size YoY Growth 2016-2027
8.2 Asia Pacific Bicalutamide Market Facts & Figures by Region
8.2.1 Asia Pacific Bicalutamide Sales by Region (2016-2021)
8.2.2 Asia Pacific Bicalutamide Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Bicalutamide Market Size YoY Growth 2016-2027
9.2 Europe Bicalutamide Market Facts & Figures by Country
9.2.1 Europe Bicalutamide Sales by Country (2016-2021)
9.2.2 Europe Bicalutamide Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Bicalutamide Market Size YoY Growth 2016-2027
10.2 Latin America Bicalutamide Market Facts & Figures by Country
10.2.1 Latin America Bicalutamide Sales by Country (2016-2021)
10.2.2 Latin America Bicalutamide Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Bicalutamide Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Bicalutamide Market Facts & Figures by Country
11.2.1 Middle East and Africa Bicalutamide Sales by Country (2016-2021)
11.2.2 Middle East and Africa Bicalutamide Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Description and Business Overview
12.1.3 AstraZeneca Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AstraZeneca Bicalutamide Products Offered
12.1.5 AstraZeneca Recent Development
12.2 CORDEN PHARMA GMBH
12.2.1 CORDEN PHARMA GMBH Corporation Information
12.2.2 CORDEN PHARMA GMBH Description and Business Overview
12.2.3 CORDEN PHARMA GMBH Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.2.4 CORDEN PHARMA GMBH Bicalutamide Products Offered
12.2.5 CORDEN PHARMA GMBH Recent Development
12.3 Zeneca GmbH
12.3.1 Zeneca GmbH Corporation Information
12.3.2 Zeneca GmbH Description and Business Overview
12.3.3 Zeneca GmbH Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Zeneca GmbH Bicalutamide Products Offered
12.3.5 Zeneca GmbH Recent Development
12.4 Actavis Pharma
12.4.1 Actavis Pharma Corporation Information
12.4.2 Actavis Pharma Description and Business Overview
12.4.3 Actavis Pharma Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Actavis Pharma Bicalutamide Products Offered
12.4.5 Actavis Pharma Recent Development
12.5 Sivem Pharmaceuticals
12.5.1 Sivem Pharmaceuticals Corporation Information
12.5.2 Sivem Pharmaceuticals Description and Business Overview
12.5.3 Sivem Pharmaceuticals Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Sivem Pharmaceuticals Bicalutamide Products Offered
12.5.5 Sivem Pharmaceuticals Recent Development
12.6 Sorres Pharma
12.6.1 Sorres Pharma Corporation Information
12.6.2 Sorres Pharma Description and Business Overview
12.6.3 Sorres Pharma Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sorres Pharma Bicalutamide Products Offered
12.6.5 Sorres Pharma Recent Development
12.7 Fresenius Kabi
12.7.1 Fresenius Kabi Corporation Information
12.7.2 Fresenius Kabi Description and Business Overview
12.7.3 Fresenius Kabi Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Fresenius Kabi Bicalutamide Products Offered
12.7.5 Fresenius Kabi Recent Development
12.8 ANI Pharmaceuticals
12.8.1 ANI Pharmaceuticals Corporation Information
12.8.2 ANI Pharmaceuticals Description and Business Overview
12.8.3 ANI Pharmaceuticals Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.8.4 ANI Pharmaceuticals Bicalutamide Products Offered
12.8.5 ANI Pharmaceuticals Recent Development
12.9 Accel Pharma
12.9.1 Accel Pharma Corporation Information
12.9.2 Accel Pharma Description and Business Overview
12.9.3 Accel Pharma Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Accel Pharma Bicalutamide Products Offered
12.9.5 Accel Pharma Recent Development
12.10 Apotex Corporation
12.10.1 Apotex Corporation Corporation Information
12.10.2 Apotex Corporation Description and Business Overview
12.10.3 Apotex Corporation Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Apotex Corporation Bicalutamide Products Offered
12.10.5 Apotex Corporation Recent Development
12.11 AstraZeneca
12.11.1 AstraZeneca Corporation Information
12.11.2 AstraZeneca Description and Business Overview
12.11.3 AstraZeneca Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.11.4 AstraZeneca Bicalutamide Products Offered
12.11.5 AstraZeneca Recent Development
12.12 Shanghai Zhaohui Pharmaceutical
12.12.1 Shanghai Zhaohui Pharmaceutical Corporation Information
12.12.2 Shanghai Zhaohui Pharmaceutical Description and Business Overview
12.12.3 Shanghai Zhaohui Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Shanghai Zhaohui Pharmaceutical Products Offered
12.12.5 Shanghai Zhaohui Pharmaceutical Recent Development
12.13 Zhejiang Haizheng Pharmaceutical
12.13.1 Zhejiang Haizheng Pharmaceutical Corporation Information
12.13.2 Zhejiang Haizheng Pharmaceutical Description and Business Overview
12.13.3 Zhejiang Haizheng Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Zhejiang Haizheng Pharmaceutical Products Offered
12.13.5 Zhejiang Haizheng Pharmaceutical Recent Development
12.14 Shanxi Zhendong Pharmaceutical
12.14.1 Shanxi Zhendong Pharmaceutical Corporation Information
12.14.2 Shanxi Zhendong Pharmaceutical Description and Business Overview
12.14.3 Shanxi Zhendong Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Shanxi Zhendong Pharmaceutical Products Offered
12.14.5 Shanxi Zhendong Pharmaceutical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Bicalutamide Industry Trends
13.2 Bicalutamide Market Drivers
13.3 Bicalutamide Market Challenges
13.4 Bicalutamide Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bicalutamide Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Bicalutamide Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Tablets
Table 3. Major Manufacturers of Capsule
Table 4. Global Bicalutamide Market Size Growth Rate by Application (2021-2027) & (M Pcs)
Table 5. Global Bicalutamide Market Size by Region (M Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Bicalutamide Sales by Regions (2016-2021) & (M Pcs)
Table 7. Global Bicalutamide Sales Market Share by Regions (2016-2021)
Table 8. Global Bicalutamide Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Bicalutamide Sales Forecast by Region (2022-2027) & (M Pcs)
Table 10. Global Bicalutamide Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Bicalutamide Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Bicalutamide Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Bicalutamide Sales by Manufacturers (2016-2021) (M Pcs)
Table 14. Global Bicalutamide Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Bicalutamide Manufacturers by Revenue (US$ Million) in 2020
Table 16. Bicalutamide Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Bicalutamide Revenue Share by Manufacturers (2016-2021)
Table 18. Global Bicalutamide Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Bicalutamide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bicalutamide as of 2020)
Table 20. Key Manufacturers Bicalutamide Price (2016-2021) (US$/Pcs)
Table 21. Bicalutamide Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Bicalutamide Product Type
Table 23. Date of International Manufacturers Enter into Bicalutamide Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Bicalutamide Sales by Type (2016-2021) (M Pcs)
Table 26. Global Bicalutamide Sales Share by Type (2016-2021)
Table 27. Global Bicalutamide Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Bicalutamide Revenue Share by Type (2016-2021)
Table 29. Bicalutamide Average Selling Price (ASP) by Type (2016-2021) & (US$/Pcs)
Table 30. Global Bicalutamide Sales Forecast by Type (2022-2027) & (M Pcs)
Table 31. Global Bicalutamide Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Bicalutamide Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Bicalutamide Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Bicalutamide Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Pcs)
Table 35. Global Bicalutamide Sales by Application (2016-2021) (M Pcs)
Table 36. Global Bicalutamide Sales Share by Application (2016-2021)
Table 37. Global Bicalutamide Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Bicalutamide Revenue Share by Application (2016-2021)
Table 39. Bicalutamide Average Selling Price (ASP) by Application (2016-2021) & (US$/Pcs)
Table 40. Global Bicalutamide Sales Forecast by Application (2022-2027) & (M Pcs)
Table 41. Global Bicalutamide Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Bicalutamide Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Bicalutamide Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Bicalutamide Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Pcs)
Table 45. China Bicalutamide Sales (M Pcs) of Key Companies (2016-2021)
Table 46. China Bicalutamide Sales Share by Company (2016-2021)
Table 47. China Bicalutamide Revenue (US$ Million) by Company (2016-2021)
Table 48. China Bicalutamide Revenue Share by Company (2016-2021)
Table 49. China Bicalutamide Sales (M Pcs) by Type (2016-2021)
Table 50. China Bicalutamide Sales Share by Type (2016-2021)
Table 51. China Bicalutamide Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Bicalutamide Price (US$/Pcs) by Type (2016-2021)
Table 53. China Bicalutamide Sales (M Pcs) by Type (2022-2027)
Table 54. China Bicalutamide Sales Share by Type (2022-2027)
Table 55. China Bicalutamide Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Bicalutamide Revenue Share by Type (2022-2027)
Table 57. China Bicalutamide Price (US$/Pcs) by Type (2022-2027)
Table 58. China Bicalutamide Sales (M Pcs) by Application (2016-2021)
Table 59. China Bicalutamide Sales Share by Application (2016-2021)
Table 60. China Bicalutamide Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Bicalutamide Price (US$/Pcs) by Application (2016-2021)
Table 62. China Bicalutamide Sales (M Pcs) by Application (2022-2027)
Table 63. China Bicalutamide Sales Share by Application (2022-2027)
Table 64. China Bicalutamide Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Bicalutamide Revenue Share by Application (2022-2027)
Table 66. China Bicalutamide Price (US$/Pcs) by Application (2022-2027)
Table 67. North America Bicalutamide Sales by Country (2016-2021) & (M Pcs)
Table 68. North America Bicalutamide Sales Market Share by Country (2016-2021)
Table 69. North America Bicalutamide Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Bicalutamide Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Bicalutamide Sales by Region (2016-2021) & (M Pcs)
Table 72. Asia Pacific Bicalutamide Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Bicalutamide Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Bicalutamide Revenue Market Share by Region (2016-2021)
Table 75. Europe Bicalutamide Sales by Country (2016-2021) & (M Pcs)
Table 76. Europe Bicalutamide Sales Market Share by Country (2016-2021)
Table 77. Europe Bicalutamide Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Bicalutamide Revenue Market Share by Country (2016-2021)
Table 79. Latin America Bicalutamide Sales by Country (2016-2021) & (M Pcs)
Table 80. Latin America Bicalutamide Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Bicalutamide Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Bicalutamide Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Bicalutamide Sales by Country (2016-2021) & (M Pcs)
Table 84. Middle East and Africa Bicalutamide Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Bicalutamide Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Bicalutamide Revenue Market Share by Country (2016-2021)
Table 87. AstraZeneca Corporation Information
Table 88. AstraZeneca Description and Business Overview
Table 89. AstraZeneca Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 90. AstraZeneca Bicalutamide Product
Table 91. AstraZeneca Recent Development
Table 92. CORDEN PHARMA GMBH Corporation Information
Table 93. CORDEN PHARMA GMBH Description and Business Overview
Table 94. CORDEN PHARMA GMBH Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 95. CORDEN PHARMA GMBH Product
Table 96. CORDEN PHARMA GMBH Recent Development
Table 97. Zeneca GmbH Corporation Information
Table 98. Zeneca GmbH Description and Business Overview
Table 99. Zeneca GmbH Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 100. Zeneca GmbH Product
Table 101. Zeneca GmbH Recent Development
Table 102. Actavis Pharma Corporation Information
Table 103. Actavis Pharma Description and Business Overview
Table 104. Actavis Pharma Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 105. Actavis Pharma Product
Table 106. Actavis Pharma Recent Development
Table 107. Sivem Pharmaceuticals Corporation Information
Table 108. Sivem Pharmaceuticals Description and Business Overview
Table 109. Sivem Pharmaceuticals Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 110. Sivem Pharmaceuticals Product
Table 111. Sivem Pharmaceuticals Recent Development
Table 112. Sorres Pharma Corporation Information
Table 113. Sorres Pharma Description and Business Overview
Table 114. Sorres Pharma Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 115. Sorres Pharma Product
Table 116. Sorres Pharma Recent Development
Table 117. Fresenius Kabi Corporation Information
Table 118. Fresenius Kabi Description and Business Overview
Table 119. Fresenius Kabi Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 120. Fresenius Kabi Product
Table 121. Fresenius Kabi Recent Development
Table 122. ANI Pharmaceuticals Corporation Information
Table 123. ANI Pharmaceuticals Description and Business Overview
Table 124. ANI Pharmaceuticals Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 125. ANI Pharmaceuticals Product
Table 126. ANI Pharmaceuticals Recent Development
Table 127. Accel Pharma Corporation Information
Table 128. Accel Pharma Description and Business Overview
Table 129. Accel Pharma Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 130. Accel Pharma Product
Table 131. Accel Pharma Recent Development
Table 132. Apotex Corporation Corporation Information
Table 133. Apotex Corporation Description and Business Overview
Table 134. Apotex Corporation Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 135. Apotex Corporation Product
Table 136. Apotex Corporation Recent Development
Table 137. Shanghai Fudan Fuhua Pharmaceutical Corporation Information
Table 138. Shanghai Fudan Fuhua Pharmaceutical Description and Business Overview
Table 139. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 140. Shanghai Fudan Fuhua Pharmaceutical Product
Table 141. Shanghai Fudan Fuhua Pharmaceutical Recent Development
Table 142. Shanghai Zhaohui Pharmaceutical Corporation Information
Table 143. Shanghai Zhaohui Pharmaceutical Description and Business Overview
Table 144. Shanghai Zhaohui Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 145. Shanghai Zhaohui Pharmaceutical Product
Table 146. Shanghai Zhaohui Pharmaceutical Recent Development
Table 147. Zhejiang Haizheng Pharmaceutical Corporation Information
Table 148. Zhejiang Haizheng Pharmaceutical Description and Business Overview
Table 149. Zhejiang Haizheng Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 150. Zhejiang Haizheng Pharmaceutical Product
Table 151. Zhejiang Haizheng Pharmaceutical Recent Development
Table 152. Shanxi Zhendong Pharmaceutical Corporation Information
Table 153. Shanxi Zhendong Pharmaceutical Description and Business Overview
Table 154. Shanxi Zhendong Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 155. Shanxi Zhendong Pharmaceutical Product
Table 156. Shanxi Zhendong Pharmaceutical Recent Development
Table 157. Bicalutamide Market Trends
Table 158. Bicalutamide Market Drivers
Table 159. Bicalutamide Market Challenges
Table 160. Bicalutamide Market Restraints
Table 161. Bicalutamide Customers List
Table 162. Bicalutamide Distributors List
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Bicalutamide Product Picture
Figure 2. Global Bicalutamide Sales Market Share by Type in 2020 & 2027
Figure 3. Tablets Product Picture
Figure 4. Capsule Product Picture
Figure 5. Global Bicalutamide Sales Market Share by Application in 2020 & 2027
Figure 6. Single Drug For Prostate Cancer
Figure 7. Combined Chemotherapy For Prostate Cancer
Figure 8. Combined Radiation Therapy Or Castration For Prostate Cancer
Figure 9. Bicalutamide Report Years Considered
Figure 10. Global Bicalutamide Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Bicalutamide Market Size 2016-2027 (US$ Million)
Figure 12. Global Bicalutamide Sales 2016-2027 (M Pcs)
Figure 13. Global Bicalutamide Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Bicalutamide Sales Market Share by Region (2016-2021)
Figure 15. Global Bicalutamide Sales Market Share by Region in 2020
Figure 16. Global Bicalutamide Revenue Market Share by Region (2016-2021)
Figure 17. Global Bicalutamide Revenue Market Share by Region in 2020
Figure 18. Global Bicalutamide Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Bicalutamide Revenue in 2020
Figure 20. Bicalutamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Bicalutamide Sales Market Share by Type (2016-2021)
Figure 22. Global Bicalutamide Sales Market Share by Type in 2020
Figure 23. Global Bicalutamide Revenue Market Share by Type (2016-2021)
Figure 24. Global Bicalutamide Revenue Market Share by Type in 2020
Figure 25. Global Bicalutamide Sales Market Share by Application (2016-2021)
Figure 26. Global Bicalutamide Sales Market Share by Application in 2020
Figure 27. Global Bicalutamide Revenue Market Share by Application (2016-2021)
Figure 28. Global Bicalutamide Revenue Market Share by Application in 2020
Figure 29. China Bicalutamide Sales Growth Rate 2016-2027 (M Pcs)
Figure 30. China Bicalutamide Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. China Bicalutamide Market Share in Global Market 2016-2027
Figure 32. China 5 and 10 Largest Bicalutamide Players Market Share by Revenue in Bicalutamide in 2020
Figure 33. China Bicalutamide Revenue Share by Type (2016-2021)
Figure 34. China Bicalutamide Revenue Growth Rate by Type in 2016 & 2020
Figure 35. China Bicalutamide Revenue Share by Application (2016-2021)
Figure 36. China Bicalutamide Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Bicalutamide Sales Growth Rate 2016-2021 (M Pcs)
Figure 38. North America Bicalutamide Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Bicalutamide Sales Market Share by Country in 2020
Figure 40. North America Bicalutamide Revenue Market Share by Country in 2020
Figure 41. U.S. Bicalutamide Sales Growth Rate (2016-2021) (M Pcs)
Figure 42. U.S. Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Bicalutamide Sales Growth Rate (2016-2021) (M Pcs)
Figure 44. Canada Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Bicalutamide Sales Growth Rate 2016-2021 (M Pcs)
Figure 46. Europe Bicalutamide Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Bicalutamide Sales Market Share by Country in 2020
Figure 48. Europe Bicalutamide Revenue Market Share by Country in 2020
Figure 49. Germany Bicalutamide Sales Growth Rate (2016-2021) (M Pcs)
Figure 50. Germany Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Bicalutamide Sales Growth Rate (2016-2021) (M Pcs)
Figure 52. France Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Bicalutamide Sales Growth Rate (2016-2021) (M Pcs)
Figure 54. U.K. Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Bicalutamide Sales Growth Rate (2016-2021) (M Pcs)
Figure 56. Italy Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Bicalutamide Sales Growth Rate (2016-2021) (M Pcs)
Figure 58. Russia Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Bicalutamide Sales Growth Rate 2016-2021 (M Pcs)
Figure 60. Asia Pacific Bicalutamide Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Bicalutamide Sales Market Share by Region in 2020
Figure 62. Asia Pacific Bicalutamide Revenue Market Share by Region in 2020
Figure 63. China Bicalutamide Sales Growth Rate (2016-2021) (M Pcs)
Figure 64. China Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Bicalutamide Sales Growth Rate (2016-2021) (M Pcs)
Figure 66. Japan Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Bicalutamide Sales Growth Rate (2016-2021) (M Pcs)
Figure 68. South Korea Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Bicalutamide Sales Growth Rate (2016-2021) (M Pcs)
Figure 70. India Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Bicalutamide Sales Growth Rate (2016-2021) (M Pcs)
Figure 72. Australia Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Taiwan Bicalutamide Sales Growth Rate (2016-2021) (M Pcs)
Figure 74. Taiwan Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Bicalutamide Sales Growth Rate (2016-2021) (M Pcs)
Figure 76. Indonesia Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Bicalutamide Sales Growth Rate (2016-2021) (M Pcs)
Figure 78. Thailand Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Bicalutamide Sales Growth Rate (2016-2021) (M Pcs)
Figure 80. Malaysia Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Philippines Bicalutamide Sales Growth Rate (2016-2021) (M Pcs)
Figure 82. Philippines Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Vietnam Bicalutamide Sales Growth Rate (2016-2021) (M Pcs)
Figure 84. Vietnam Bicalutamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Latin America Bicalutamide Sales Growth Rate 2016-2021 (M Pcs)
Figure 86. Latin America Bicalutamide Revenue Growth Rate 2016-2021 (US$ Million)
Figure 87. Latin America Bicalutamide Sales Market Share by Country in 2020
Figure 88. Latin America Bicalutamide Revenue Market Share by Country in 2020
Figure 89. Mexico Bicalutamide S

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs